47 results on '"Brandimarte, G."'
Search Results
2. Effect of mesalazine on epithelial cell proliferation in colonic diverticular disease.
3. P.01.22 REFLUX ESOPHAGITIS AFTER H.P. ERADICATION: THE ROLE OF GASTRIC ACID SECRETION.
4. P.01.29 GASTRIC ULCER: RISK FACTORS, HELICOBACTER PYLORI INFECTION AND NSAIDS USE IN A SAMPLE OF 256 PEOPLE.
5. P.06.24 HISTOLOGICAL GHRELIN EXPRESSION CORRELATES WITH ECL PROLIFERATION AND CHROMOGRANIN A IMMUNOEXPRESSION: A COMPARATIVE STUDY BETWEEN ATROPHIC AND NON-ATROPHIC GASTRITIS.
6. P.01.19 HOMOCYSTEINE IN CHRONIC ATROPHIC GASTRITIS: A STUDY ON IMMUNOHISTOCHEMICAL PATTERNS IN GASTRIC MUCOSA.
7. P.06.14 EFFECTIVENESS AND SAFETY OF PYLERA® IN PATIENTS INFECTED BY HELICOBACTER PYLORI: A LARGE, PROSPECTIVE, REAL LIFE STUDY.
8. P.06.10 NATURAL HISTORY OF GASTRIC ULCER IN A 25 YEARS FOLLOW-UP: ROLE OF HELICOBACTER PYLORI INFECTION AND NONSTEROIDAL ANTI-INFLAMMATORY DRUGS.
9. P.05.7 EPIDEMIOLOGY OF DIVERTICULAR DISEASE OF THE COLON: A PRELIMINARY ANALYSIS FROM THE INTERNATIONAL “DICA” PROSPECTIVE STUDY.
10. P.06.30 RISK FACTORS FOR ONSET OF ESOPHAGITIS IN A LONG 15 YEARS FOLLOW-UP.
11. OC.03.4 IMPACT OF TREATMENTS ON FECAL MICROBIOTA AND FECAL METABOLIC PROFILING IN SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE OF THE COLON.
12. P.02.5 SIX-YEAR EFFICACY AND SAFETY OF AZATHIOPRINE TREATMENT IN THE MAINTENANCE OF STEROID-FREE REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENTS.
13. P.11.1: Azathioprine in the Maintenance of Steroid-Free Remission in Inflammatory Bowel Disease Patients: Efficacy and Safety in Five Years of Follow-Up.
14. P.01.5: Serum Pepsinogen II as a Non-Invasive Marker for Diagnosis of Helicobacter Pylori Infection: A Prospective Study in a Cohort of Dyspeptic Patients.
15. P.07.2: Natural History of Symptomatic Uncomplicated Diverticular Disease: A 13-Year Prospective Study.
16. P.07.7: Impact of Endoscopic Classification “Dica” on the Burden of Diverticular Disease of the Colon in Italy.
17. OC.10.2: Fecal Microbiota, Fecal and Urinary Metabolic Profiling and Symptomatic Uncomplicated Diverticular Disease of the Colon.
18. P.02.7: The Branded Proton Pump Inhibitors (PPIS) Increase Levels of Gastrin 17 (G-17) More than the Generic Ones in Dyspeptic Patients from an Italian Primary Care Population.
19. PC.01.2 PREDICTIVE VALUE OF THE “DICA” ENDOSCOPIC CLASSIFICATION ON THE OUTCOME OF THE DIVERTICULAR DISEASE OF THE COLON: AN INTERNATIONAL STUDY.
20. P.07.13 FOUR-YEAR EFFICACY AND SAFETY OF AZATHIOPRINE TREATMENT IN THE MAINTAINANCE OF STEROID-FREE REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENTS.
21. P.09.12 ASSESSMENT OF FECAL MICROBIOTA AND FECAL METABOLOME IN SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE OF THE COLON.
22. OC.05.5 DEVELOPMENT AND VALIDATION OF AN ENDOSCOPIC CLASSIFICATION OF DIVERTICULAR DISEASE OF THE COLON: THE DICA CLASSIFICATION.
23. P.06.25 INFLIXIMAB AND ADALIMUMAB FOR CROHN'S DISEASE IN REAL LIFE: EFFECTIVENESS, SAFETY AND ABILITY IN OBTAINING MUCOSAL AND HISTOLOGICAL HEALING.
24. P.11.7 FECAL CALPROTECTIN IN PREDICTING RECURRENCE AFTER ATTACK OF COLONIC DIVERTICULITIS.
25. P.11.6 MODERATE-TO-SEVERE AND PROLONGED LEFT LOWER ABDOMINAL PAIN IS THE BEST SYMPTOM CHARACTERIZING SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE OF THE COLON: A COMPARISON WITH FECAL CALPROTECTIN IN CLINICAL SETTING.
26. P.06.11 HISTOLOGICAL INFLAMMATION IN ULCERATIVE COLITIS IN DEEP REMISSION UNDER TREATMENT WITH INFLIXIMAB.
27. P.19.5 EFFICACY, TOLERABILITY AND FACTORS AFFECTING THE EFFICACY OF THE SEQUENTIAL THERAPY IN CURING HELICOBACTER PYLORI INFECTION IN CLINICAL SETTING.
28. P.12.11 PERSISTENCE OF INFLAMMATION AFTER AN ATTACK OF COLONIC DIVERTICULITIS IS A RISK FACTOR OF DIVERTICULITIS RECURRENCE.
29. P.12.9 MUCOSAL TUMOUR NECROSIS FACTOR-ALPHA IN DIVERTICULAR DISEASE OF THE COLON IS OVEREXPRESSED IN RELATION TO THE SEVERITY OF THE DISEASE.
30. P.1.307: INFLAMMATORY MANIFESTATIONS AT COLONOSCOPY IN PATIENTS WITH COLONIC DIVERTICULAR DISEASE.
31. P.1.126: SEGMENTAL COLITIS ASSOCIATED WITH DIVERTICULOSIS: A 5-YEARS FOLLOW-UP.
32. P.1.191: FACTORS INFLUENCING MUCOSAL HEALING IN CROHN'S DISEASE DURING INFLIXIMAB TREATMENT IN CLINICAL PRACTICE.
33. P.1.293: EFFECTIVENESS OF DIFFERENT THERAPEUTIC STRATEGIES IN PREVENTING DIVERTICULITIS RECURRENCE.
34. P.1.195: PERSISTENCE OF ENDOSCOPIC AND HISTOLOGICAL INFLAMMATION AFTER ATTACK OF COLONIC DIVERTICULITIS AS RISK FACTORS OF DIVERTICULITIS RECURRENCE.
35. P.93 TUMOUR NECROSIS FACTOR-ALPHA EXPRESSION IN SEGMENTAL COLITIS ASSOCIATED WITH DIVERTICULOSIS IS RELATED TO THE SEVERITY OF THE ENDOSCOPIC DAMAGE.
36. CAN ENDOSCOPY DIFFERENTIATE BETWEEN ULCERATIVE COLITIS WITH DIVERTICULOSIS, SEGMENTAL COLITIS ASSOCIATED WITH DIVERTICULOSIS (“SCAD” SYNDROME) AND ACUTE UNCOMPLICATED COLONIC DIVERTICULITIS? A PROSPECTIVE STUDY.
37. PREDICTIVE VALUE OF SEROLOGICAL MARKERS OF DEGREE OF HISTOLOGICAL DAMAGE IN ACUTE UNCOMPLICATED COLONIC DIVERTICULITIS.
38. SUPPLEMENTATION WITH THE PROBIOTIC VSL#3 IN PATIENTS WITH MILD-TO-MODERATE ACTIVE ULCERATIVE COLITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY.
39. PA.173 THE ENDOSCOPIC SPECTRUM OF SEGMENTAL COLITIS ASSOCIATED WITH DIVERTICULOSIS (“DIVERTICULAR COLITIS”).
40. PA.168 MUCOSAL HEALING IN ULCERATIVE COLITIS PATIENTS IN LONG-TERM TREATMENT WITH INFLIXIMAB.
41. PA.60 EFFECT OF MESALAZINE ON EPITHELIAL CELL PROLIFERATION IN COLONIC DIVERTICULAR DISEASE.
42. PA.47 COMPLICATIONS IN COELIAC DISEASE UNDER GLUTEN-FREE DIET.
43. OC1.01.2 FECAL CALPROTECTIN IN COLONIC DIVERTICULAR DISEASE: A CASE-CONTROL STUDY AND COMPARISON IN IRRITABLE BOWEL SYNDROME AND HEALTHY PEOPLE.
44. Beclometasone dipropionate plus VSL#3 for the treatment of mild-to-moderate diverticular colitis.
45. Epithelial cell proliferation index of the colonic mucosa in colonic diverticular disease.
46. Effect of a symbiotic preparation on the clinical manifestations of Irritable Bowel Syndrome, constipation-variant: Results of a multicenter study.
47. Peripheral neurological disturbances, autonomic dysfunction and anti-neuronal antibodies in adult Coeliac Disease before and after gluten-free diet.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.